Michael C. Thigpen

5.7k total citations · 1 hit paper
47 papers, 2.6k citations indexed

About

Michael C. Thigpen is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Michael C. Thigpen has authored 47 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 14 papers in Virology and 14 papers in Epidemiology. Recurrent topics in Michael C. Thigpen's work include HIV/AIDS Research and Interventions (23 papers), HIV Research and Treatment (14 papers) and HIV/AIDS drug development and treatment (11 papers). Michael C. Thigpen is often cited by papers focused on HIV/AIDS Research and Interventions (23 papers), HIV Research and Treatment (14 papers) and HIV/AIDS drug development and treatment (11 papers). Michael C. Thigpen collaborates with scholars based in United States, Uganda and Malawi. Michael C. Thigpen's co-authors include Mary Glenn Fowler, Taha E. Taha, Lynne Mofenson, Johnstone Kumwenda, Donald R. Hoover, Elizabeth R. Zell, Monica E. Parise, Anne Schuchat, Ruth Lynfield and Arthur Reingold and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

Michael C. Thigpen

47 papers receiving 2.5k citations

Hit Papers

Bacterial Meningitis in the United States, 1998–2007 2011 2026 2016 2021 2011 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael C. Thigpen United States 26 1.3k 1.2k 668 499 462 47 2.6k
Mark W. Kline United States 32 1.7k 1.3× 839 0.7× 330 0.5× 158 0.3× 821 1.8× 116 2.7k
Ari Bitnun Canada 28 1.1k 0.8× 1.3k 1.1× 443 0.7× 349 0.7× 208 0.5× 112 2.5k
Annemarie M. C. van Rossum Netherlands 32 844 0.7× 1.7k 1.5× 511 0.8× 731 1.5× 474 1.0× 93 2.8k
Audrey L. French United States 36 1.8k 1.4× 1.7k 1.5× 283 0.4× 633 1.3× 926 2.0× 183 4.5k
Andrea Kovács United States 38 2.4k 1.9× 1.8k 1.5× 289 0.4× 345 0.7× 1.7k 3.6× 133 4.4k
Tessa Goetghebuer Belgium 24 748 0.6× 819 0.7× 172 0.3× 203 0.4× 259 0.6× 53 2.0k
Begoña Martínez de Tejada Switzerland 29 485 0.4× 1.1k 0.9× 583 0.9× 373 0.7× 89 0.2× 136 2.5k
Alan Karstaedt South Africa 27 1.2k 0.9× 1.2k 1.0× 236 0.4× 202 0.4× 312 0.7× 67 2.1k
Henrik Nielsen Denmark 30 1.0k 0.8× 974 0.8× 330 0.5× 538 1.1× 246 0.5× 145 3.1k
Ellen G. Chadwick United States 29 1.3k 1.0× 804 0.7× 202 0.3× 98 0.2× 635 1.4× 119 2.6k

Countries citing papers authored by Michael C. Thigpen

Since Specialization
Citations

This map shows the geographic impact of Michael C. Thigpen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Thigpen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Thigpen more than expected).

Fields of papers citing papers by Michael C. Thigpen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Thigpen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Thigpen. The network helps show where Michael C. Thigpen may publish in the future.

Co-authorship network of co-authors of Michael C. Thigpen

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Thigpen. A scholar is included among the top collaborators of Michael C. Thigpen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Thigpen. Michael C. Thigpen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Thigpen, Michael C., Sann Chan Soeung, Paul Kitsutani, et al.. (2022). Improving community coverage of Japanese encephalitis vaccination: lessons learned from a mass campaign in Battambang Province, Cambodia. BMC Public Health. 22(1). 2244–2244. 1 indexed citations
3.
Cutland, Clare, Stephanie J. Schrag, Michael C. Thigpen, et al.. (2015). Increased Risk for Group BStreptococcusSepsis in Young Infants Exposed to HIV, Soweto, South Africa, 2004–20081. Emerging infectious diseases. 21(4). 638–645. 57 indexed citations
4.
Niska, Richard W, Charles E. Rose, Faith L. Henderson, et al.. (2014). Bone Mineral Density Changes among HIV-Uninfected Young Adults in a Randomised Trial of Pre-Exposure Prophylaxis with Tenofovir-Emtricitabine or Placebo in Botswana. PLoS ONE. 9(3). e90111–e90111. 61 indexed citations
5.
Hudgens, Michael G., Taha E. Taha, Saad B. Omer, et al.. (2012). Pooled Individual Data Analysis of 5 Randomized Trials of Infant Nevirapine Prophylaxis to Prevent Breast-Milk HIV-1 Transmission. Clinical Infectious Diseases. 56(1). 131–139. 13 indexed citations
6.
Thigpen, Michael C., Scott Filler, Peter N. Kazembe, et al.. (2011). Associations between Peripheral Plasmodium falciparum Malaria Parasitemia, Human Immunodeficiency Virus, and Concurrent Helminthic Infection among Pregnant Women in Malawi. American Journal of Tropical Medicine and Hygiene. 84(3). 379–385. 27 indexed citations
7.
Thomas, Timothy K., Rose Masaba, Craig B. Borkowf, et al.. (2011). Triple-Antiretroviral Prophylaxis to Prevent Mother-To-Child HIV Transmission through Breastfeeding—The Kisumu Breastfeeding Study, Kenya: A Clinical Trial. PLoS Medicine. 8(3). e1001015–e1001015. 138 indexed citations
8.
Taha, Taha E., Li Q, Donald R. Hoover, et al.. (2011). Postexposure Prophylaxis of Breastfeeding HIV-Exposed Infants With Antiretroviral Drugs to Age 14 Weeks: Updated Efficacy Results of the PEPI-Malawi Trial. JAIDS Journal of Acquired Immune Deficiency Syndromes. 57(4). 319–325. 27 indexed citations
9.
Hudelson, Sarah E., Michelle S. McConnell, Danstan Bagenda, et al.. (2010). Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS. 24(4). 557–561. 15 indexed citations
10.
Li, Qing, Donald R. Hoover, George Kafulafula, et al.. (2010). Addition of extended zidovudine to extended nevirapine prophylaxis reduces nevirapine resistance in infants who were HIV-infected in utero. AIDS. 24(3). 381–386. 15 indexed citations
11.
Harris, Julie, Sharon K. Greene, Timothy K. Thomas, et al.. (2009). Effect of a Point‐of‐Use Water Treatment and Safe Water Storage Intervention on Diarrhea in Infants of HIV‐Infected Mothers. The Journal of Infectious Diseases. 200(8). 1186–1193. 29 indexed citations
12.
Church, Jessica D., Anthony Mwatha, Danstan Bagenda, et al.. (2009). In Utero HIV Infection Is Associated with an Increased Risk of Nevirapine Resistance in Ugandan Infants Who Were Exposed to Perinatal Single Dose Nevirapine. AIDS Research and Human Retroviruses. 25(7). 673–677. 16 indexed citations
13.
Kumwenda, Johnstone, Donald R. Hoover, Lynne Mofenson, et al.. (2008). Extended Antiretroviral Prophylaxis to Reduce Breast-Milk HIV-1 Transmission. New England Journal of Medicine. 359(2). 119–129. 266 indexed citations
14.
McConnell, Michelle S., Paul M. Bakaki, Danstan Bagenda, et al.. (2007). Effectiveness of Repeat Single-Dose Nevirapine for Prevention of Mother-to-Child Transmission of HIV-1 in Repeat Pregnancies in Uganda. JAIDS Journal of Acquired Immune Deficiency Syndromes. 46(3). 291–296. 23 indexed citations
15.
Peters, Philip J., Michael C. Thigpen, Monica E. Parise, & Robert D. Newman. (2007). Safety and Toxicity of Sulfadoxine/Pyrimethamine. Drug Safety. 30(6). 481–501. 124 indexed citations
16.
Kourtis, Athena P., Denise J. Jamieson, Isabelle de Vincenzi, et al.. (2007). Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. American Journal of Obstetrics and Gynecology. 197(3). S113–S122. 37 indexed citations
17.
Thigpen, Michael C.. (2005). Bacterial Meningitis in the United States-1998-2003. 5 indexed citations
18.
Thigpen, Michael C.. (2004). Incidence and Characteristics of Invasive Group A Streptococcal Infection Among Residents of Long-Term Care Facilities - 1998-2003. 2 indexed citations
19.
Castellano‐Sanchez, Amilcar A., et al.. (2003). Acanthamoeba castellani encephalitis following partially mismatched related donor peripheral stem cell transplantation. Transplant Infectious Disease. 5(4). 191–194. 25 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026